dr-resham-babu-amgai-scientist-biotechnology-unit-nepal-agriculture-research-council-narc-khumaltar-lalitpur-nepal

Nepal agri council: We get $5 mn for R&D each year

  • Rest of Asia
  • |
  • Influencers
  • |
  • By Rahul Koul in Kathmandu, Nepal
  • |
  • 0 Comment

The National Agricultural Research Council (NARC) is Nepal's premier agriculture agency under the ministry of agriculture, whose function is to support the growth... Read more

mr-joshua-hexter-the-new-coo-and-vp-of-business-development-for-oramed

Joshua Hexter is new COO, VP of BD for Oramed

  • Rest of Asia
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Oramed Pharmaceuticals appointed Mr Joshua Hexter as chief operating officer and vice president of business development. Mr Hexter received his BA from... Read more

good-news-for-diabetes-patients-oramed-pharma-files-investigational-new-drug-ind-for-its-oral-insulin-candidate-with-us-fda

Oramed files oral insulin IND with US FDA

  • US
  • |
  • Regulatory
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Israel-based Oramed Pharmaceuticals, a developer of oral drug delivery systems, submitted a new Investigational New Drug (IND) application to the US FDA... Read more

pakistan-alleges-that-india-does-not-follow-the-necessary-drug-regulation-policies-as-prescribed-by-the-world-health-organization-who-and-should-not-be-granted-most-favoured-nation-mfn-status

Pakistan protests against India's MFN status

  • India
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

New Delhi: Pharmaceutical industry associations in Pakistan have protested against the granting of most-favoured nation (MFN) status to India alleging that India... Read more

impending-free-trade-agreement-between-gcc-and-india-will-further-open-up-the-generics-market

Gulf nations woo Indian generic firms

  • India
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: A new report by investment bank Alpen Capital titled, 'The GCC pharmaceutical Outlook', a number of Gulf Cooperation Council (GCC) countries are seeking... Read more

orcell-can-heal-damaged-tissue-using-muscle-stem-cells

Orcell heals damaged tissue using muscle stem cells

  • Rest of Asia
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 1 Comment

Singapore: Israel-based Andain has come up with a new technology called Orcell that rehabilitates and heals damaged muscle tissue by initiating regenerative myogenic... Read more

medigene-syncore-agreement

Medigene, SynCore expand deal for Veregen

  • Australia
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Germany-headquartered Medigene and SynCore Biotechnology, a member of Sinphar Pharmaceutical Group, have expanded the existing exclusive licensing and... Read more

beximco-pharma-exporter-eu

Beximco Pharma enters EU market

  • Rest of Asia
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Beximco Pharmaceuticals, a manufacturer of generic pharmaceutical products and active pharmaceutical ingredients in Bangaldesh, has commenced export of... Read more

agreed-groupe-athena-will-assist-eskayef-in-obtaining-fda-approval-for-their-bangladesh-manufacturing-facility

Groupe Athena, Eskayef Bangladesh join hands

  • India
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Mumbai: Groupe Athena has entered into a multiyear contract with Eskayef Bangladesh, a leading Indian pharmaceutical manufacturer. Under the terms of the agreement,... Read more

Special Features

Survey Box

Ranbaxy Controversy

Will the Ranbaxy controversy end the Indian pharma dominion in the US market?

Send this article by email

X